Not applicableUnknownNCT03663153What this trial is testingSEMA4C as a Relapse Biomarker in Breast CancerWho this might be right forBreast Cancer Tongji Hospital 4,200
Testing effectiveness (Phase 2)WithdrawnNCT02713984What this trial is testingA Clinical Research of CAR T Cells Targeting HER2 Positive CancerWho this might be right forBreast CancerOvarian CancerLung Cancer+4 more Zhi Yang
Not applicableUnknownNCT00815555What this trial is testingCYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer PatientsWho this might be right forBreast Cancer Assaf-Harofeh Medical Center 500
Testing effectiveness (Phase 2)Ended earlyNCT00461344What this trial is testingDocetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast CancerWho this might be right forDuctal Carcinoma Sanofi 20
Testing effectiveness (Phase 2)UnknownNCT05089643What this trial is testingAnrotinib in Combination With Capecitabine in Advanced Triple Negative Breast CancerWho this might be right forMetastatic Triple-Negative Breast Cancer Chinese Academy of Medical Sciences 35
Testing effectiveness (Phase 2)WithdrawnNCT00964704What this trial is testingHerceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche
Early research (Phase 1)Active Not RecruitingNCT03742245What this trial is testingOlaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast CancerWho this might be right forBreast Cancer MetastaticBreast Cancer The Methodist Hospital Research Institute 28
Post-approval studies (Phase 4)Study completedNCT01301729What this trial is testingHerceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin TreatmentWho this might be right forBreast Cancer Hoffmann-La Roche 32
Not applicableWithdrawnNCT01558778What this trial is testingMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT05192798What this trial is testingAlbumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBCWho this might be right forTriple-negative Breast Cancer The First Affiliated Hospital of Bengbu Medical University 128
Large-scale testing (Phase 3)Study completedNCT02214381What this trial is testingA Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low ResponseWho this might be right forEarly Primary Breast Cancer Women's Cancer Study Group GmbH 80
Not applicableStudy completedNCT00082654What this trial is testingStudy of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00126451What this trial is testingA Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)Who this might be right forBreast CancerColorectal CancerNon-small-cell Lung Carcinoma Merck Sharp & Dohme LLC 16
Not applicableStudy completedNCT01306188What this trial is testingPrognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer PatientsWho this might be right forBreast CancerLung Cancer Centre Leon Berard 179
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00316407What this trial is testingLapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer PatientsWho this might be right forOvarian Epithelial Cancer Stage IIIStage IV Ovarian CancerStage IV Breast Cancer Swedish Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06508216What this trial is testingExplore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast CancerWho this might be right forBreast Cancer Gustave Roussy, Cancer Campus, Grand Paris 50
Not applicableWithdrawnNCT00898612What this trial is testingEarly Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forLymphoma Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT00305448What this trial is testingA Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mgWho this might be right forAdvanced Breast CancerMetastatic Breast Cancer AstraZeneca 143
Testing effectiveness (Phase 2)Study completedNCT00193037What this trial is testingDoxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast CancerWho this might be right forBreast Cancer SCRI Development Innovations, LLC 102